amobarbital has been researched along with Chagas Disease in 2 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
Chagas Disease: Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Titto, EH | 1 |
Cardoni, RL | 2 |
Rimoldi, MT | 1 |
de Bracco, MM | 1 |
2 other studies available for amobarbital and Chagas Disease
Article | Year |
---|---|
Trypanosoma cruzi: parasite-induced release of lysosomal enzymes by human polymorphonuclear leukocytes.
Topics: Amobarbital; Azides; Chagas Disease; Cyanides; Cytochalasin B; Glucuronidase; Humans; Muramidase; Ne | 1983 |
Antibody-dependent cytotoxicity of human and mouse mononuclear cells against Trypanosoma cruzi epimastigotes.
Topics: Amitrole; Amobarbital; Animals; Antibody-Dependent Cell Cytotoxicity; Azides; Cell Adhesion; Chagas | 1984 |